Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketoprofen Cataplasms for Pain Relief in Patients with Knee Osteoarthritis
ChiCTR2400092881Phase 4Not yet recruiting
- Sponsor
- The Second Xiangya Hospital
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ketoprofen in knee osteoarthritis (OA) (3 arms), sponsored by The Second Xiangya Hospital. Primary endpoint: Western Ontario and McMaster University Osteoarthritis Index (WOMAC) total score. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
ketoprofen
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2400092881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092881.